Traditional Chinese medicine for treating polycystic ovarian syndrome

Abstract

The invention discloses a traditional Chinese medicine for treating a polycystic ovarian syndrome. The traditional Chinese medicine is characterized by being prepared from the following medical materials in parts by weight: 12 parts of seed of Japanese banana, 10 parts of white beans, 9 parts of the penis of white horse, 9 parts of fructus psoraleae, 12 parts of saussurea involucrate, 9 parts of syngnathus, 9 parts of flatstem milkvetch seed, 12 parts of salvia chinensis, 9 parts of fruits of polygonum orientale, 9 parts of artemisia anomala, 12 parts of Chinese trumpet creeper, 9 parts of rhizoma sparganii, 9 parts of curcuma zedoary, 9 parts of rhizoma curcumae longae, 15 parts of rehmannia glutinosa, 18 parts of cornu cervi degelatinatum, 12 parts of cuscuta chinensis, 12 parts of raspberry, 15 parts of common fenugreek seed, 15 parts of herba epimedii, 15 parts of manis pentadactyla, 9 parts of aconitum carmichaelii, 6 parts of cortex cinnamomi, 15 parts of cistanche, 18 parts of the fruit of Chinese wolfberry, 12 parts of loranthus parasiticus, 12 parts of angelica sinensis, 12 parts of placenta hominis, 9 parts of roasted folium artemisiae argyi, 12 parts of morinda officinalis, 12 parts of fluoritum, 18 parts of codonopsis pilosula, 18 parts of rhizoma atractylodis macrocephalae, 6 parts of pinellia ternata, 6 parts of bile arisaema, 6 parts of leech, 12 parts of spina gleditsiae, 10 parts of Chinese yam, 25 parts of radix astragali preparata, 3 pieces of fresh ginger and 10 parts of Chinese dates. The clinical experiment proves that the traditional Chinese medicine can be used for safely and effectively treating the polycystic ovarian syndrome.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicine, in particular to a traditional Chinese medicine for treating polycystic ovary syndrome. Background technique [0002] Polycystic ovary syndrome (PCOS) is an endocrine disorder syndrome in which reproductive dysfunction and abnormal glucose metabolism coexist. Persistent anovulation, polyfollicular immaturity, androgen excess, and insulin resistance are important features and are the most common causes of menstrual disorders in women of reproductive age. With menstrual disorders, amenorrhea, anovulation, hirsutism, obesity, infertility and bilateral ovarian enlargement showed cystic changes. Patients may have the above typical symptoms, or only some symptoms, but infertility due to ovulation disorders is the main clinical manifestation of polycystic ovary syndrome. Polycystic ovary syndrome is similar to the categories of "late menstruation", "amenorrhea" and "infertility" in traditio...

AI Technical Summary

Problems solved by technology

For polycystic ovary syndrome, there is still a lack of recognized safe and effective treatment drugs